Hypoxia-responsive liposome enhances intracellular delivery of photosensitizer for effective photodynamic therapy.

Bibliographic Details
Title: Hypoxia-responsive liposome enhances intracellular delivery of photosensitizer for effective photodynamic therapy.
Authors: Li, Peishan1 (AUTHOR), Li, Jiaxin1 (AUTHOR), Cheng, Jinmei1 (AUTHOR), Huang, Junyi1,2 (AUTHOR), Li, Jinhui3 (AUTHOR), Xiao, Jisheng1,2 (AUTHOR) jsx031@smu.edu.cn, Duan, Xiaopin1 (AUTHOR) xpduan@smu.edu.cn
Source: Journal of Controlled Release. Jan2025, Vol. 377, p277-287. 11p.
Subject Terms: *RETICULO-endothelial system, *PHOTODYNAMIC therapy, *PHOTOSENSITIZERS, *POLYETHYLENE glycol, *TUMOR microenvironment, *LIPOSOMES
Abstract: Liposomes, especially polyethylene glycol (PEG)-modified long-circulating liposomes, have been approved for market use, due to good biocompatibility, passive tumor targeting, and sustained drug release. PEG-modified long-circulating liposomes address issues such as poor stability and rapid clearance by the reticuloendothelial system. However, they still face challenges like hindering drug uptake by tumor cells and preventing tumor penetration. Inspired by the hypoxic tumor microenvironment, we constructed a hypoxia-responsive liposome (PAO-L) to enhance the intracellular uptake and photodynamic therapy (PDT) effect of chlorin e6 (Ce6). The intelligent hypoxia-cleavable PEG-AZO-OA (PAO) was prepared by coupling PEG and octadecylamine (OA) to hypoxia-sensitive azobenzene-4,4′-dicarboxylic acid (AZO) through amide reaction. The synthesized PAO was further incorporated into Ce6-loaded liposomes to enhance the circulation stability, while promote the tumor penetration and internalization by the responsive shedding of PEG from liposome surface upon reaching the hypoxic tumor tissue. PAO-L mediated PDT significantly inhibited the growth of B16F10 and 4T1 tumors, as well as lung metastasis of 4T1 breast cancer. The excellent therapeutic effect and good tolerability make PAO-L a promising candidate for enhanced PDT. [Display omitted] [ABSTRACT FROM AUTHOR]
Copyright of Journal of Controlled Release is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Academic Search Complete
More Details
ISSN:01683659
DOI:10.1016/j.jconrel.2024.11.032
Published in:Journal of Controlled Release
Language:English